GILGAMESH PHARMACEUTICALS
Live / Applied — Revived — awaiting further action (as of 02 Jul 2026)
What this means for you
Not registered yet, but its 29 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97526318
- Mark type
- Word mark
- Filed
- 29 Jul 2022
- Published for opposition
- 26 Sept 2023
- Attorney of record
- Keith A. Weltsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical and drug preparations and substances for use in treating cancer and for use in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for medical use, namely, for pharmaceuticals and drugs for use in treating cancer and in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, dementia, sleep disorders, attention deficit disorder, autism, and longevity
Owner
- GILGAMESH PHARMACEUTICALS, INC., New York, NY, US
- GILGAMESH PHARMACEUTICALS, INC., New York, NY, US
Prosecution history
- 02 Jul 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 02 Jul 2026 — NOTICE OF REVIVAL - E-MAILED
- 02 Jul 2026 — PETITION TO REVIVE-GRANTED
- 02 Jul 2026 — TEAS PETITION TO REVIVE RECEIVED
- 22 Jun 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Jun 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 22 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2025 — SOU EXTENSION 4 GRANTED
- 21 Nov 2025 — SOU EXTENSION 4 FILED
- 21 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 3 GRANTED
- 16 May 2025 — SOU EXTENSION 3 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED